Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,003 | -15,217 | -7,636 | -35,709 | -26,606 |
| Depreciation Amortization | 296 | 208 | 125 | 638 | 421 |
| Accounts payable and accrued liabilities | 28 | -240 | 12 | 1 | -89 |
| Other Working Capital | -2,334 | -1,514 | -1,723 | 868 | -662 |
| Other Operating Activity | 2,831 | 2,068 | 919 | 3,130 | 2,343 |
| Operating Cash Flow | $-21,182 | $-14,695 | $-8,303 | $-31,072 | $-24,593 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -163 | -163 | -46 | -562 | -206 |
| Investing Cash Flow | $-163 | $-163 | $-46 | $-562 | $-206 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -4,739 | N/A |
| Common Stock Issued | 1,253 | 1,232 | 44 | 8,861 | 8,849 |
| Other Financing Activity | 0 | 0 | 0 | 7,281 | 7,280 |
| Financing Cash Flow | $1,253 | $1,232 | $44 | $11,403 | $16,129 |
| Beginning Cash Position | 31,598 | 31,598 | 31,598 | 51,829 | 51,829 |
| End Cash Position | 11,506 | 17,972 | 23,293 | 31,598 | 43,159 |
| Net Cash Flow | $-20,092 | $-13,626 | $-8,305 | $-20,231 | $-8,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,182 | -14,695 | -8,303 | -31,072 | -24,593 |
| Capital Expenditure | -163 | -163 | -46 | -562 | -206 |
| Free Cash Flow | -21,345 | -14,858 | -8,349 | -31,634 | -24,799 |